Brazil's SUS to prioritize vulnerable groups for injectable PrEP

Brazil's Conitec gave a preliminary favorable recommendation for cabotegravir as injectable PrEP, with the Ministry of Health planning to expand prevention options. The move targets vulnerable populations, though final approval and rollout details remain pending. This signals a shift toward long-acting HIV prevention in Brazil's public health system.